The Financial Comet
  • Business
  • World News
  • Politics
  • Investing
  • Business
  • World News
  • Politics
  • Investing

The Financial Comet

Investing

Chemphys Placement Participation Funds Received

by admin January 28, 2025
January 28, 2025
Chemphys Placement Participation Funds Received

Galan Lithium Limited (ASX: GLN) (Galan or the Company) is pleased to advise that it has received proceeds from Latam Resources Pty Limited (Latam), an Affiliate of Chengdu Chemphys Chemical Industry Co., Ltd (Chemphys) in relation to the share placement (Placement) announced by the Company on 10 September 2024 and subsequently approved by shareholders at the Galan Annual General Meeting held on 15 November 2024. Chemphys agreed to subscribe for US$3 million worth of shares under the terms of the Placement.

Funds received from Latam will be applied by Galan towards ongoing Phase 1 operations at Hombre Muerto West (HMW), as parties continue to work towards finalising an offtake prepayment facility targeted financial close during the first quarter of 2025.

Click here for the full ASX Release

This post appeared first on investingnews.com

previous post
Vale Launches Strategic Review of Thompson Nickel Operations Amid Market Challenges
next post
Republicans vie to replace Matt Gaetz in crowded 10-way special election primary

Related Posts

5 Biggest AI ETFs in 2025

March 6, 2025

Editor’s Picks: Silver Price Hits 13 Year High,...

June 22, 2025

Forum Energy Metals and Global Uranium Announce Exploration...

January 31, 2025

E-Power Resources Inc. Announces Flow-Through and Hard Dollar...

June 12, 2025

Nickel Price Update: Q1 2025 in Review

April 23, 2025

Investing in Gold Royalty and Streaming Stocks

February 25, 2025

Precious Metals & Critical Minerals Hybrid Investor Conference:...

May 25, 2025

Top 5 Canadian Mining Stocks This Week: Minsud...

February 22, 2025

RHI: Acqn of royalty over Sandstone Gold Project...

April 28, 2025

Blue Lagoon Announces Final Tranche Of Private Placement

April 17, 2025

    Join our mailing list to get access to special deals, promotions, and insider information. Your exclusive benefits await! Enjoy personalized recommendations, first dibs on sales, and members-only content that makes you feel like a true VIP. Sign up now and start saving!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Editors’ Picks

    • 1

      Trump re-designates Iranian-backed Houthis as terrorists: ‘Threaten[s] security of American civilians’

      January 23, 2025
    • 2

      DeepSeek hit with large-scale cyberattack, says it’s limiting registrations

      January 28, 2025
    • 3

      Bank of America CEO says financial industry will jump into crypto payments if regulators allow it

      January 23, 2025
    • 4

      FDA officially authorizes Zyn nicotine pouches for sale following health review

      January 23, 2025
    • 5

      Universal’s ‘Wicked: For Good’ creates a unique marketing challenge

      January 27, 2025
    • 6

      UnitedHealthcare taps company veteran Tim Noel as new CEO following Brian Thompson killing

      January 27, 2025
    • 7

      Lara Trump to host weekend show on Fox News

      February 7, 2025
    • About us
    • Contacts
    • Privacy Policy
    • Terms and Conditions
    • Email Whitelisting

    Disclaimer: thefinancialcomet.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 thefinancialcomet.com | All Rights Reserved